Published in Obesity and Diabetes Week, January 12th, 2004
U.S. Patent No. 6,659,982 is the second patent issued for the new patch infusion technology. Additional patent applications are pending. The patch is for use with insulin pumps worn by people with diabetes to control their insulin levels.
The annual U.S. insulin pump infusion set market is approximately $270 million.
"We are very pleased with the news of the additional patent, and continue to be greatly encouraged by comments from pump users who have evaluated the patch," said Bill Arthur, SpectRx, Inc. president and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week